Strong growth in its isotope products segment contributed to record sales for isotope technology firm Eckert & Ziegler in its third quarter.
For the period (end-September 30), the company produced sales of 123.8 million euros, up 23% from the 100.4 million euros reported in the third quarter of 2017.
In quarterly highlights, the company's isotope products generated 83.7 million euros in sales, up 31% compared with the same period a year ago. Meanwhile, brisk demand for its pharmaceutical radioisotopes helped the firm's radiopharma segment achieve 23.5 million euros in sales, a 14% increase compared with the 2017 third quarter, according to the vendor. Thanks to sales gains from its high-dose rate products, Eckert & Ziegler's radiation therapy segment had sales of 21.1 million euros, up 15% from the last year's third quarter.
The vendor had quarterly profits of 13.6 million euros, compared with 9.5 million euros a year ago.
